Active Ingredient (In Each Tablet)
Ranitidine 75 mg (as ranitidine hydrochloride, USP 84 mg)
The following Structured Product Label (SPL) was submitted to the FDA by Dr. Reddy's Laboratories Limited for the product Ranitidine (NDC 55111-131). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredient (in each tablet), purpose, uses, warnings, do not use, ask a doctor before use if you have, ask a doctor or pharmacist before use if you are, stop use and ask a doctor if, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Ranitidine 75 mg (as ranitidine hydrochloride, USP 84 mg)
Acid reducer
Allergy alert: Do not use if you are allergic to ranitidine or other acid reducers
• taking a prescription drug. Acid reducers may interact with certain prescription drugs.
FD&C red #40 aluminum lake, hypromellose, iron oxide black, magnesium stearate, microcrystalline cellulose, polyethylene glycol, titanium dioxide.
* Please review the disclaimer below.